BCLSI
Bain Capital Life Sciences Investors Portfolio holdings
AUM $799M
1-Year Return
36.47%
This Quarter Return
+29.87%
1 Year Return
+36.47%
3 Year Return
+278.05%
5 Year Return
+363.53%
10 Year Return
–
AUM
$799M
AUM Growth
+$123M
(+18%)
Cap. Flow
+$73.7M
Cap. Flow
% of AUM
9.22%
Top 10 Holdings %
Top 10 Hldgs %
87.4%
Holding
24
New
–
Increased
3
Reduced
2
Closed
1
Top Buys
| 1 |
Cidara Therapeutics
CDTX
|
+$87.6M |
| 2 |
Cabaletta Bio
CABA
|
+$10.5M |
| 3 |
UPB
Upstream Bio, Inc. Common Stock
UPB
|
+$1.58M |
Top Sells
| 1 |
Disc Medicine
IRON
|
+$21.2M |
| 2 |
Dianthus Therapeutics
DNTH
|
+$3.86M |
| 3 |
Nautilus Biotechnolgy
NAUT
|
+$923K |
Sector Composition
| 1 | Healthcare | 99.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
NewAmsterdam Pharma
NAMS
$2.74B
| $194M | 24.29% |
10,719,110
| – | – |
|
|
2
Cidara Therapeutics
CDTX
$1.66B
| $122M | 15.24% |
2,500,680
+1,797,600
| +256% | +$87.6M |
|
3
Nuvalent
NUVL
$5.73B
| $110M | 13.82% |
1,447,267
| – | – |
|
4
Pharvaris
PHVS
$1.53B
| $58.1M | 7.27% |
3,303,381
| – | – |
|
|
5
Dianthus Therapeutics
DNTH
$1.48B
| $46.2M | 5.79% |
2,482,250
-207,457
| -8% | -$3.86M |
|
6
Savara
SVRA
$627M
| $40.1M | 5.02% |
17,600,621
| – | – |
|
7
Solid Biosciences
SLDB
$431M
| $38.5M | 4.82% |
7,911,669
| – | – |
|
|
8
Disc Medicine
IRON
$2.09B
| $30.9M | 3.87% |
583,500
-400,000
| -41% | -$21.2M |
|
9
Olema Pharmaceuticals
OLMA
$555M
| $29.2M | 3.65% |
6,843,954
| – | – |
|
10
Rapid Micro Biosystems
RPID
$135M
| $29.1M | 3.64% |
8,434,560
| – | – |
|
|
UPB
11
Upstream Bio, Inc. Common Stock
UPB
$955M
| $26.8M | 3.35% |
2,439,538
+144,216
| +6% | +$1.58M |
|
|
12
Cabaletta Bio
CABA
$181M
| $14.7M | 1.84% |
9,677,125
+6,916,237
| +251% | +$10.5M |
|
13
Tango Therapeutics
TNGX
$794M
| $13.9M | 1.74% |
2,712,008
| – | – |
|
14
Annexon
ANNX
$284M
| $12.6M | 1.58% |
5,249,069
| – | – |
|
15
Kyverna Therapeutics
KYTX
$174M
| $10.3M | 1.29% |
3,368,370
| – | – |
|
16
Atea Pharmaceuticals
AVIR
$239M
| $8.95M | 1.12% |
2,485,638
| – | – |
|
17
Xilio Therapeutics
XLO
$38.9M
| $3.1M | 0.39% |
4,566,817
| – | – |
|
18
Century Therapeutics
IPSC
$42.2M
| $3.02M | 0.38% |
5,410,361
| – | – |
|
19
Mersana Therapeutics
MRSN
$36.3M
| $2.56M | 0.32% |
346,547
| – | – |
|
20
C4 Therapeutics
CCCC
$243M
| $1.59M | 0.2% |
1,111,910
| – | – |
|
21
Invivyd
IVVD
$264M
| $1.29M | 0.16% |
1,799,595
| – | – |
|
22
X4 Pharmaceuticals
XFOR
$67.6M
| $1.07M | 0.13% |
563,859
| – | – |
|
|
23
NewAmsterdam Pharma Company N.V. Warrant
NAMSW
$58.4M
| $800K | 0.1% |
100,000
| – | – |
|
|
24
Nautilus Biotechnolgy
NAUT
$94.4M
| – | – |
-1,072,421
| Closed | -$923K |
|